Clinical Data

three spotlights on a stage
Biotech

Merck KGaA sheds light on failed portion of phase 2 lupus trial

Merck KGaA has shed light on the failure in one lupus cohort, while pointing to secondary endpoint wins as proof that enpatoran still deserves a shot.
James Waldron Jun 12, 2025 9:41am
Coral reef sea underwater

Merck's oral PCSK9 inhibitor leader reduces cholesterol in ph. 3

Jun 9, 2025 9:00am
Alzheimers research brain scientist magnifying glass questions neuro

NewAmsterdam links lipid drug to drop in Alzheimer's biomarker

Jun 9, 2025 8:25am
obesity overweight weight loss weigh

Metsera posts amylin data, eyes monthly GLP-1 combo

Jun 9, 2025 7:00am
Human kidney anatomy

Otsuka's kidney disease drug halves UPCR levels in ph. 3 study

Jun 6, 2025 6:26am
An artists depiction of DNA molecules made up of tiny particles

RegenXBio links DMD gene therapy to improved outcomes

Jun 5, 2025 8:52am